Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart sensors could predict falls in older adults with dizziness

NCT ID NCT07751354

Knowledge-focused Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study evaluates a sensor-based version of the Timed Up and Go test (QTUG) for measuring balance and predicting fall risk in older adults with dizziness (vestibulopathy). Researchers will compare QTUG results with other balance tests, track whether a six-month vestibular rehabilitation program improves balance, and see if the test can predict who will fall within a year. The goal is to determine if QTUG is a reliable tool to help doctors identify those at risk and monitor treatment progress.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vestibular rehabilitation (a program of exercises to improve balance and reduce dizziness)
What this could lead to
If the QTUG test proves reliable, it could give doctors a simple, sensor-based way to measure balance problems, predict fall risk, and track whether vestibular rehab is helping older adults with dizziness.
What could go wrong
This is an early-stage study, and the QTUG test may not prove more accurate than existing balance tests. The results may not apply to all older adults with dizziness, and the rehab program's benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Older adults (aged \>65) * Diagnosis of vestibular pathology including unilateral vestibulopathy/vestibular neuritis or bilateral vestibulopathy, Meniere disease, vestibular associated migraines, PPPD, Presby vestibulopathy (PVP), vestibular paroxysmia, vestibular schwannoma, third window syndrome. * Able to walk independently with or without walking aid. * Able to provide consent Exclusion Criteria: * Visual impairment. * Diagnosis of Benign paroxysmal positional vertigo (BPPV) or haemodynamic dizziness (Postural hypotension, cardiogenic dizziness/POTS, heart arrythmia, heart attack). * Diagnosis of neurological disorder such as: multiple sclerosis, cerebrovascular accident, Parkinson's disease, dementia, diabetic neuropathy, epilepsy. * Not fluent in English. * Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Meniere disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acoustic neuroma Meniere disease semicircular canal dehiscence syndrome vestibular disorder vestibular neuronitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vestibulopathy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Royal Hallamshire Hospital

    Sheffield, South Yorkshire, S10 2JF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.